Evidence map›Paper›PMID 35532553›Full record

ArticleThe Journal of experimental medicine2022

Hypoxia induces adrenomedullin from lung epithelia, stimulating ILC2 inflammation and immunity.

Jihye Han, Qingqing Wan, Goo-Young Seo, Kenneth Kim, Sarah El Baghdady, Jee H Lee, Mitchell Kronenberg, Yun-Cai Liu

Open access · greenAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Group 2 innate lymphoid cells: Where are we 15 years out?The Journal of allergy and clinical immunology · 2026
    Review
  4. Roles of the Altitude-Adapted Immune Microenvironment in Pulmonary Vascular Remodeling in High-Altitude Pulmonary Hypertension: A Review.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. The immunology of asthma.Nature immunology · 2025
    Review
  10. Review
  11. Adrenomedullin in Tumorigenesis and Cancer Progression.International journal of molecular sciences · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Adrenomedullin improved endothelial dysfunction via receptor-Akt pathway in rats with obesity-related hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Jihye HanLa Jolla Institute for Immunology, La Jolla, CA.ORCID 0000-0002-9477-0270
Qingqing WanLa Jolla Institute for Immunology, La Jolla, CA.ORCID 0000-0002-0004-7250
Goo-Young SeoLa Jolla Institute for Immunology, La Jolla, CA.ORCID 0000-0001-5517-724X
Kenneth KimLa Jolla Institute for Immunology, La Jolla, CA.ORCID 0000-0002-5993-4575
Sarah El BaghdadyLa Jolla Institute for Immunology, La Jolla, CA.ORCID 0000-0001-9565-512X
Jee H LeeLa Jolla Institute for Immunology, La Jolla, CA.ORCID 0000-0002-6095-0783
Mitchell KronenbergLa Jolla Institute for Immunology, La Jolla, CA.ORCID 0000-0001-6318-6445
Yun-Cai LiuLa Jolla Institute for Immunology, La Jolla, CA.ORCID 0000-0002-0996-7109
La Jolla Institute for Immunology · US

Funding

Differentiation of subsets of NKT cellsR01AI071922 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI KRONENBERG, MITCHELL · 2016 to 2020
$2.7M
HVEM: A TNF family receptor that influences mucosal immunity and the microbiomeU01AI125955 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI KRONENBERG, MITCHELL · 2016 to 2020
$2.7M
Regulation of innate lymphoid cells in inflammationR01AI123398 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI KRONENBERG, MITCHELL · 2016 to 2020
$2.2M
FACSAria II Cell SorterS10RR027366 · NCRR · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2011 to 2011
$514k
NCRR NIH HHS S10 RR027366NIAID NIH HHS R01 AI071922NIAID NIH HHS R01 AI123398NIAID NIH HHS U01 AI125955NIH HHS S10RR027366
6 · The paper itself

Abstract

Hypoxia contributes to airway inflammation and remodeling in several lung diseases; however, exactly how hypoxic pulmonary epithelium regulates allergic inflammation remains to be fully characterized. Here, we report that conditional deletion of the E3 ubiquitin ligase VHL in lung epithelial cells resulted in exacerbated type 2 responses accompanied by selective increase of group 2 innate lymphoid cells (ILC2s) at steady state and following inflammation or helminth infection. Ablation of expression of the hypoxia-inducible factor 2α (HIF2α) significantly reversed VHL-mediated ILC2 activation. VHL deficiency in lung epithelial cells caused increased expression of the peptide hormone adrenomedullin (ADM), and our data suggest that HIF2α controls Adm expression. ADM directly promoted ILC2 activation both in vitro and in vivo. Our findings indicate that the hypoxic response mediated by the VHL-HIF2α axis is critical for control of pulmonary type 2 responses by increasing ADM expression in lung epithelia, causing ILC2 activation.

Indexed as

Immunity, InnateLung DiseasesAdrenomedullinEpitheliumHumansHypoxiaInflammationLungLymphocytesAdrenomedullin

Identifiers

PMID35532553
PMCPMC9093746
OpenAlexW4229368367

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.